Ignet
Search (e.g., vaccine, IFNG): Help
About
Home
Introduction
Statistics
Programs
Dignet
Gene
GenePair
BioSummarAI
Help & Docs
Documents
Help
FAQs
Links
Acknowledge
Disclaimer
Contact Us
UM Logo

UMMS Logo

UMMS Logo

Gene Information

Gene symbol: EPHA2

Gene name: EPH receptor A2

HGNC ID: 3386

Related Genes

# Gene Symbol Number of hits
1 ABCB11 1 hits
2 ABHD12 1 hits
3 ABO 1 hits
4 ASGR1 1 hits
5 ATP8B1 1 hits
6 CD276 1 hits
7 CDH6 1 hits
8 EFNA1 1 hits
9 EPHA4 1 hits
10 EPHA7 1 hits
11 FADS1 1 hits
12 FADS2 1 hits
13 FUT2 1 hits
14 GCKR 1 hits
15 GGT1 1 hits
16 GPLD1 1 hits
17 GSTT1 1 hits
18 GSTT2 1 hits
19 HNF1A 1 hits
20 JMJD1C 1 hits
21 MICAL3 1 hits
22 MLXIPL 1 hits
23 PNPLA3 1 hits
24 PPP1R3B 1 hits
25 RORA 1 hits
26 SLC2A2 1 hits
27 ST3GAL4 1 hits
28 STAT4 1 hits
29 TRIB1 1 hits
30 ZNF827 1 hits

Related Sentences

# PMID Sentence
1 17177142 The erythropoietin-producing hepatoma amplified sequence (Eph) receptors and their ligands-the ephrins- are a recently detected family of membrane located protein tyrosine kinases which play a crucial role in the growth and development of nerve and blood vessel network.
2 17177142 The mRNA of EphA4, EphA7, ephrinA4, ephrinB1 and ephrinB2 was detected in GC and EC, while EphA2 was expressed only in GC.
3 22001757 We identified 69 candidate genes, including genes involved in biliary transport (ATP8B1 and ABCB11), glucose, carbohydrate and lipid metabolism (FADS1, FADS2, GCKR, JMJD1C, HNF1A, MLXIPL, PNPLA3, PPP1R3B, SLC2A2 and TRIB1), glycoprotein biosynthesis and cell surface glycobiology (ABO, ASGR1, FUT2, GPLD1 and ST3GAL4), inflammation and immunity (CD276, CDH6, GCKR, HNF1A, HPR, ITGA1, RORA and STAT4) and glutathione metabolism (GSTT1, GSTT2 and GGT), as well as several genes of uncertain or unknown function (including ABHD12, EFHD1, EFNA1, EPHA2, MICAL3 and ZNF827).
4 22910142 The bioreducible cationic polymer poly(cystamine bisacrylamide-diamino hexane) (p(CBA-DAH)) was modified with poly(ethylene glycol) (PEG) and the targeting peptide CHVLWSTRC, known to target the EphA2 and EphA4 receptors.